Search for an ETF or holding
Franklin Genomic Advancements ETF
HELX (Franklin Genomic Advancements ETF) is an US Equity ETF by Franklin. With a 0.50% MER, it provides diversified exposure through 53 holdings. Annual distribution with a 0.43% yield.
HELX is an ETF offered by Franklin.
With a 0.50% MER, its fees are in line with category averages. It does not pay a significant distribution — returns are reinvested for capital growth.
As a US-listed ETF, it is typically held in an RRSP to minimize withholding tax on US dividends (Canada-US tax treaty).